Should clinicians be extra vigilant when deciding who receives antiviral therapy, or are the adverse effects few and infrequent?
Desirae Lindquist, PharmD, BCPS
Advertisement
Articles by Desirae Lindquist, PharmD, BCPS
Advertisement
Latest Updated Articles
- Risks Associated With Direct-Acting Antivirals—Smoke or Fire?
Published: May 9th 2017 | Updated:
Advertisement
Advertisement